Self‐Assembled Peptide‐Derived Proteolysis‐Targeting Chimera (PROTAC) Nanoparticles for Tumor‐Targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy
Angewandte Chemie International Edition · 27.01.2025 · 64 (5)
DOI: 10.1002/anie.202414146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 17.12.2024. Verfasst von Yujeong Moon und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea. Hauptthemen laut MEDLINE: Nanoparticles, B7-H1 Antigen, Peptides, Immunotherapy. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Samsung Research Funding & Incubation Center for Future Technology of Samsung Electronics, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Proteolysis‐targeting chimeras (PROTACs) are a promising technique for the specific and durable degradation of cancer‐related proteins via the ubiquitin‐proteasome system in cancer treatment. However, the therapeutic efficacy of PROTACs is restricted due to their hydrophobicity, poor cell permeability and insufficient tumor‐targeting ability. Herein, we develop the self‐assembled peptide‐derived PROTAC nanoparticles (PT‐NPs) for precise and durable programmed death‐ligand 1 (PD−L1) degradation in targeted tumors. The PT‐NPs with an average size of 211.8 nm are formed through the self‐assembly of amphiphilic peptide‐derived PROTAC (CLQKTPKQC‐FF‐ALAPYIP), comprising a PD−L1‐targeting ‘CLQKTPKQC’, self‐assembling linker ‘FF’ and E3 ligase recruiting ‘ALAPYIP’. Particularly, PT‐NPs strongly bind to tumor cell surface PD−L1 to form PD−L1/PT‐NPs complex, then internalized through receptor‐mediated endocytosis and degraded in lysosomes. Second, free PROTACs released from PT‐NPs to the cytoplasm further induce the durable proteolysis of cytoplasmic PD−L1 via the ubiquitin‐proteasome system. In colon tumor models, intravenously injected PT‐NPs accumulate significantly at targeted tumor tissues through nanoparticle‐derived passive and active targeting. At the targeted tumor tissues, PT‐NPs promote durable PD−L1 degradation and ultimately trigger a substantial antitumor immune response. Collectively, this study provides valuable insights into the rational design of self‐assembled peptide‐derived PROTAC nanoparticles to ensure noticeable accuracy and enhanced efficacy in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
- Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
- Department of Bioengineering, Korea University, Seoul, 02841, Republic of Korea.
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
- Research Center for Bioconvergence Analysis, Korea Basic Science Institute (KBSI), Cheongju, 28119, Republic of Korea.
- Department of Toxicology, College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.
ORCID-Profile: Kwangmeyung Kim
Förderung
- Samsung Research Funding & Incubation Center for Future Technology of Samsung Electronics
- Ministry of Science and ICT, South Korea
Zitieren
APA
Moon, Y., Cho, H., Kim, J., Song, S., Yeon Park, J., Young Min, J., Hee Han, E., Kim, Y., Seong, J. K., Kyu Shim, M., & Kim, K. (2025). Self‐Assembled Peptide‐Derived Proteolysis‐Targeting Chimera (PROTAC) Nanoparticles for Tumor‐Targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy. Angewandte Chemie International Edition, 64(5). https://doi.org/10.1002/anie.202414146
Vancouver
Moon Y, Cho H, Kim J, Song S, Yeon Park J, Young Min J, et al. Self‐Assembled Peptide‐Derived Proteolysis‐Targeting Chimera (PROTAC) Nanoparticles for Tumor‐Targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy. Angewandte Chemie International Edition. 2025;64(5). doi:10.1002/anie.202414146
BibTeX
@article{Moon2025,
author = {Moon, Yujeong and Cho, Hanhee and Kim, Jinseong and Song, Sukyung and Yeon Park, Jung and Young Min, Jin and Hee Han, Eun and Kim, Yongju and Seong, Joon-Kyung and Kyu Shim, Man and Kim, Kwangmeyung},
title = {Self‐Assembled Peptide‐Derived Proteolysis‐Targeting Chimera (PROTAC) Nanoparticles for Tumor‐Targeted and Durable PD‐L1 Degradation in Cancer Immunotherapy},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {5},
doi = {10.1002/anie.202414146}
}
EUVIMED